MedPath
HSA Approval

AA PHARMA METHYLDOPA TABLET 250 mg

SIN03618P

AA PHARMA METHYLDOPA TABLET 250 mg

AA PHARMA METHYLDOPA TABLET 250 mg

July 15, 1989

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

C02AB01

methyldopa (levorotatory)

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

APOTEX INC

Active Ingredients

METHYLDOPA

250 mg

Methyldopa

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.